| 1 |
PereiraJM, LaszczyńskaO, AzevedoA, et al. Early prediction of treatment failure in severe community-acquired pneumonia: the PRoFeSs score？[J]. J Crit Care, 2019, 53: 38-45.
|
| 2 |
GüellE, Martín-FernandezM, De la TorreMC, et al. Impact of lymphocyte and neutrophil counts on mortality risk in severe community-acquired pneumonia with or without septic shock？[J]. J ClinMed, 2019, 8(5)．pii：E754.
|
| 3 |
Mauri T, Turrini C, Eronia N, et al. Physiologic Effects of High-flow nasal cannula in acute hypoxemic Respiratory failure[J]. Am J Respir Crit Care Med, 2017, 195(9): 1207-1215.
|
| 4 |
李正东，詹庆元. 经鼻高流量氧疗[J]. 中国临床新医学，2019, 12(1): 5-9.
|
| 5 |
Dysart K, Miller TL, Wolfson MR, et al. Research in high flow therapy: mechanisms of action[J]. Respir Med, 2009, 103(10): 1400-11405.
|
| 6 |
Hasani A, Chapman TH, McCool D, et al. Domiciliaryhumidification improves lung mucociliary clearance inpatients with bronchiectasis[J]. Chron Respir Dis, 2008, 5(2): 81-86.
|
| 7 |
黄琳娜，李正东，夏金根，等. 经鼻高流量氧疗在急性呼吸衰竭治疗中的应用[J]．中华结核和呼吸杂志，2019, 42(1): 41-44.
|
| 8 |
中华医学会呼吸病学分会呼吸危重症医学学组，中国医师协会呼吸医师分会危重症医学工作委员会. 成人经鼻高流量湿化氧疗临床规范应用专家共识[J]. 中华结核和呼吸杂志，2019, 42(2): 83-91.
|
| 9 |
Bin Cao, Hainv Gao, Boping Zhou, et al. Adjuvant corticosteroid treatment in adults with influenza A (H7N9) viral pneumonia[J]. Crit Care Med, 2016, 44(6): e318-e328.
|
| 10 |
De Pascale G, Bello G, Antonelli M. Steroids in severe pneumonia: a literature review[J]. Minerva Anestesiol, 2011, 77(9): 902-910.
|
| 11 |
Schuliga Michael, Vancurova Ivana. NF-κappa B signaling in chronic inflammatory airway disease[J]. Biomolecules, 2015, 5(3): 1266-1283.
|
| 12 |
Long B, Koyfman A. Controversies in corticosteroid use for sepsis[J]. J Emerg Med, 2017, 53(5): 653-661.
|
| 13 |
Avrom Caplan, Nicole Fett, Misha Rosenbach, et al. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Infectious complications and vaccination recommendations[J]. J Am Acad Dermatol, 2017, 76(2): 191-198.
|
| 14 |
Oray M, Abu Samra K, Ebrahimiadib N, et al. Long-term side effects of glucocorticoid[J]. Expert Opin Drug Saf, 2016, 15(4): 457-465.
|
| 15 |
Chatterjee Arjun B. Review: Corticosteroids reduce mechanical ventilation and ARDS in inpatients with community-acquired pneumonia[J]. Ann Int Med, 2015, 163(12): JC2.
|
| 16 |
Li H, Yang SG, Gu L, et al. Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia[J]. Influenza Other Respir Viruses, 2017, 11(4): 345-354.
|
| 17 |
Chen R, Tang X, Tan Y, et al. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience[J]. Chest, 2006, 129(6): 1441-1452.
|
| 18 |
Wan YD, Sun TW, Liu ZQ, et al. Efficacy and safety of corticosteroids for community-acquired pneumonia：A systematic review and meta-analysis[J]. Chest, 2016, 149(1): 209-219.
|
| 19 |
Salluh Jorge IF, Soares Márcio, Coelho Luis M, et al. Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: a cohort study[J]. J Crit Care, 2011, 26(2): 193-200.
|
| 20 |
Adcock IM, Mumby S. Glucocorticoids[J]. Handb Exp Pharmacol, 2017, 237: 171-196.
|
| 21 |
Vandewalle J, Luypaert A, De Bosscher K, et al. Therapeutic mechanisms of glucocorticoids[J]. Trends Endocrinol Metab, 2018, 29(1): 42-54.
|